Pharmaceuticals

Global Pericarditis Market Set To Expand To $11.72 Billion By 2030 At 7.1% CAGR

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Pericarditis Market In 2026, And How Will Its Value Evolve By 2030?

Recent years have witnessed a robust expansion in the pericarditis market size. Forecasts indicate its increase from $2.49 billion in 2025 to $2.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.9%. The expansion observed in the historic period was driven by factors such as limited understanding of pericarditis, a reliance on conventional diagnostic approaches, minimal adoption of advanced imaging, restricted availability of specialized cardiac care, and the dominance of hospital-based treatment.

The pericarditis market is anticipated to experience substantial expansion in the coming years. It is projected to reach $3.64 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. This anticipated growth during the forecast period is fueled by factors such as the increasing prevalence of cardiovascular disorders, the wider adoption of digital diagnostic tools, the expansion of outpatient surgical centers, greater investment in precision medicine, and the incorporation of AI into cardiac care. Key trends identified for the forecast period encompass personalized pericarditis treatment approaches, advancements in minimally invasive surgical techniques, novel early diagnostic innovations, the integration of wearable devices for cardiac monitoring, and the broadening of outpatient cardiac care services.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9170&type=smp

What Leading Drivers Are Supporting The Pericarditis Market Expansion?

The expanding occurrence of cardiovascular diseases is anticipated to accelerate the pericarditis market’s future growth. Cardiovascular diseases are defined as conditions impacting the heart or its blood vessels, frequently associated with arterial fatty deposits and a heightened risk of blood clots. Given that untreated pericarditis can result in numerous cardiovascular diseases or, in severe instances, fatalities, the escalating incidence of these conditions is propelling market expansion. As an illustration, the American Heart Association, a US-based non-profit organization, reported in January 2024 that the age-adjusted death rate attributed to cardiovascular disease rose to 233.3 per 100,000 in 2024, representing a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the rising prevalence of cardiovascular diseases is significantly contributing to the expansion of the pericarditis devices market.

How Is Segmentation Applied In The Pericarditis Market Segment Analysis?

The pericarditis market covered in this report is segmented –

1) By Type: Acute Pericarditis, Chronic Pericarditis, Recurrent Pericarditis

2) By Diagnosis And Treatment: Electrocardiogram (ECG), Echocardiogram, Computerized Tomography (Ct), X-Ray, Medication, Surgical Treatment

3) By Application: Hospitals And Clinics, Medical Institutes, Ambulatory Surgical Centers, Research Organizations

Subsegments:

1) By Acute Pericarditis: Viral Pericarditis, Bacterial Pericarditis, Idiopathic Pericarditis

2) By Chronic Pericarditis: Constrictive Pericarditis, Non-constrictive Chronic Pericarditis

3) By Recurrent Pericarditis: Post-Acute Pericarditis Recurrences, Secondary Recurrent Pericarditis

What Trends Are Affecting The Growth Of The Pericarditis Market?

Leading firms within the pediatric market are innovating next-generation monoclonal antibodies, aiming to broaden treatment possibilities, elevate therapeutic results, and diminish adverse effects for children suffering from diverse health issues. These advanced monoclonal antibodies are designed to deliver heightened effectiveness, precision, and safety in addressing diseases. A notable example occurred in January 2024 when Coherus BioSciences, a US biotechnology enterprise, introduced LOQTORZITM. LOQTORZI finds application alongside cisplatin and gemcitabine as a primary therapy for adults diagnosed with metastatic or recurrent locally advanced nasopharyngeal carcinoma (NPC). Furthermore, it serves as a standalone treatment for individuals with recurrent, unresectable, or metastatic NPC who have experienced disease progression following platinum-based chemotherapy, irrespective of their PD-L1 status.

Who Are The Companies Participating In The Pericarditis Market Environment?

Major companies operating in the pericarditis market are Pfizer Inc., AstraZeneca plc, Merck & Co. Inc., Novartis International AG, Johnson & Johnson Services Inc., Takeda Pharmaceutical Co. Ltd., Zydus Cadila Healthcare Ltd., Sun Pharmaceutical Ltd., Kiniksa Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Amgen Inc., Merck KGaA, Hikma Pharmaceuticals plc, AbbVie Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Bayer AG, Roche Holding AG, Daiichi Sankyo Company Limited, Astellas Pharma Inc.

Get The Full Pericarditis Market Report:

https://www.thebusinessresearchcompany.com/report/pericarditis-global-market-report

Which Region Leads The Pericarditis Market In Terms Of Market Share?

North America was the largest region in the pericarditis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the pericarditis market report during the forecast period. The regions covered in the pericarditis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pericarditis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pericarditis-global-market-report

Browse Through More Reports Similar to the Global Pericarditis Market 2026, By The Business Research Company

Pericarditis Market Report 2026

https://www.thebusinessresearchcompany.com/report/pericarditis-global-market-report

Peptic Ulcer Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

Cardiac Valve Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795